Stand Up To Cancer - Science Leadership: Phillip A. Sharp

Science Leadership

Who We Are  >  Science Leadership

Stand Up To Cancer is backed by a driven and collaborative group of researchers and scientific advisors who make incredible research breakthroughs possible.

SCIENTIFIC ADVISORY COMMITTEE

Chaired by Nobel laureate Phillip A. Sharp, PhD, SU2C’s Scientific Advisory Committee is comprised of highly accomplished researchers, physicians and patient advocates.

William G. Nelson, MD, PhD
 | 
Chair

Director, Sidney Kimmel Comprehensive
Cancer Center
Johns Hopkins University

 

View Bio | View Institution

John D. Carpten, PhD
 | 
Vice Chair

Chief Scientific Officer
Irell & Manella Cancer Center
Director’s Distinquished Chair
Morgan & Helen Chu Director’s Chair
Beckman Research Institute
Professor, Integrative Translational Sciences
City of Hope

 

View Bio | View Institution

Arnold J. Levine, PhD
 | 
Vice Chair

Professor Emeritus
Institute for Advanced Study and
Cancer Institute of New Jersey

 

View Bio | View Institution

Carlos L. Arteaga, MD

Lisa K. Simmons Distinguished Chair in
Comprehensive Oncology
Director, UTSW Harold C. Simmons Cancer Center
Professor of Medicine
Associate Dean of Oncology Programs

 

View Institution

Michael A. Caligiuri, MD

Professor
Department of Hematology & Hematopoietic
Cell Transplantation
City of Hope

 

View Institution

Steven Carr, PhD

Senior Director of Proteomics and Institute
Scientist
Broad Institute

View Institution

Jenny C. Chang, MD

Emily Herrmann Chair in Cancer Research and
Director
Methodist Cancer Center at Houston Methodist
Hospital

View Institution

Alan D. D’Andrea, MD

Director, Susan F. Smith Center for Women’s
Cancers
Dana-Farber Cancer Institute

View Institution

Luis A. Diaz, Jr., MD

Division of Solid Tumor Oncology
Grayer Family Chair
Memorial Sloan Kettering Cancer Center

View Institution

S. Gail Eckhardt, MD

Associate Dean of Experimental Therapeutics
Baylor College of Medicine
Associate Director of Translational Research
Dan L Duncan Comprehensive Cancer Center

View Institution

Michael Fischbach, PhD

Liu (Liao) Family Professor of Bioengineering
Stanford University

View Institution

Judy E. Garber, MD, MPH

Chief, Division for Cancer Genetics and Prevention
Dana-Farber Cancer Institute

 

View Institution

Richard B. Gaynor, MD

President, Research and Development
BioNTech US Inc.

 

View Institution

Laurie H. Glimcher, MD

President and CEO
Principal Investigator, Cancer Immunology and Virology
Richard and Susan Smith Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School

 

View Institution

Nancy F. Goodman, JD

Executive Director and Founder
Kids v Cancer

 

View Institution

James L. Gulley, MD, PhD

Co-Director, Center for immuno-Oncology
Clinical Director
Center for Cancer Research
National Cancer Institute

 

View Institution

Michael B. Kastan, MD, PhD

Director
Duke Cancer Institute

 

View Institution

David Kaufman, MD, PhD

Partner
Third Rock Ventures

 

View Institution

David G. Kirsch, MD, PhD

Senior Scientist
Peter and Shelagh Godsoe Chair in Radiation Medicine
Princess Margaret Cancer Centre

 

View Institution

Guillermina (Gigi) Lozano, PhD

Chairman and Professor
University of Texas MD Anderson
Cancer Center

 

View Institution

Lecia Sequist, MD, MPH

Landry Family Professor of Medicine
Harvard Medical School
Program Director, Cancer Early Detection and Diagnostics Clinic
Massachusetts General Cancer Center

 

View Institution

Arlene Sharpe, MD, PhD

George Fabyan Professor
of Comparative Pathology
Co-Director, Harvard Institute of
Translational Immunology
Co-Director, Evergrande Center for
Immunologic Diseases Harvard Medical School

 

View Institution

Laura K. Shawver, PhD

President and Chief Executive Officer
Capstan Therapeutics

 

View Institution

Peter Sorger, PhD

Otto Krayer Professor
Department of Systems Biology
Head of the Harvard Program in Therapeutic
Sciences – HiTS
Harvard Medical School

 

View Institution

David A. Tuveson, MD, PhD

Professor and Director
Cold Spring Harbor Laboratory Cancer Center

 

View Institution

EMERITUS MEMBERS

Elizabeth H. Blackburn, PhD

Professor Emerita
The University of California, San Francisco

 

View Institution

Lisa Diller, MD

Chief Medical Officer
Dana-Farber Cancer Institute/ Boston Children’s Cancer and Blood Disorders Center

 

View Institution

William N. Hait, MD, PhD

Global Head of External Innovation
Janssen, Pharmaceutical Companies of Johnson & Johnson

 

View Institution

William G. Kaelin, Jr., MD

Sidney Farber Professor of Medicine,
Harvard Medical School
Dana-Farber Cancer Institute

 

View Institution

Tak W. Mak, PhD

Chief Scientific Officer
Campbell Family Institute
University of Toronto

 

View Institution

Andre Nussenzweig, PhD

Chief, Laboratory of Genome Integrity
NIH Distinguished Investigator
Center for Cancer Research National
Cancer Institute

 

View Institution

Roderic I. Pettigrew, PhD, MD

CEO of engineering Health (enHealth)
Robert A. Welch Professor and Executive Dean
School of Engineering Medicine
Texas A&M University and Houston Methodist
Hospital

 

View Institution

Cecil B. Pickett, PhD

President, R&D (retired)
Biogen Inc.

 

View Institution

Carol L. Prives, PhD

Da Costa Professor
Columbia University

 

View Institution

Phillip A. Sharp, PhD

Institute Professor
Koch Institute for Integrative Cancer Research
Massachusetts Institute of Technology

 

View Institution

SU2C Committee for Health Equity In Cancer Clinical Trials (HEC)

John D. Carpten, PhD
 | 
Chair

Chief Scientific Officer
Irell & Manella Cancer Center
Director’s Distinquished Chair
Morgan & Helen Chu Director’s Chair
Beckman Research Institute
Professor, Integrative Translational Sciences
City of Hope

 

View Bio | View Institution

Andrew T. Chan, MD, MPH

Professor of Medicine
Harvard Medical School

 

View Institution

Shawna Hudson, PhD

Professor and Research Division Chief,
Department of Family Medicine
and Community Health
Rutgers Robert Wood Johnson Medical School

 

View Institution

Chanita Hughes-Halbert, PhD

Vice Chair for Research and Professor,
Department of Population and Public Health Sciences
Associate Director for Cancer Equity
Norris Comprehensive Cancer Center
University of Southern California

 

View Institution

Elizabeth Jaffee, MD

Deputy Director
The Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins University

 

View Institution

Guillermina (Gigi) Lozano, PhD

Chairman and Professor
The University of Texas MD Anderson
Cancer Center

 

View Institution

William G. Nelson, MD, PhD

Director
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins University

 

View Institution

John Whyte, MD, MPH

Chief Medical Officer
WebMD

 

View Institution

Raymond M. Williams, JD

Senior Counsel
DLA Piper

 

View Institution

David R. Wilson, PhD

Associate Vice President Health Research
Chair, Department of Indigenous Health
School of Medicine and Health Sciences
University of North Dakota

 

View Institution

Karen Winkfield, MD, PhD

Executive Director
Meharry-Vanderbilt Alliance

 

View Institution

Robert A. Winn, MD

Director
Massey Cancer Center
Virginia Commonwealth University

 

View Institution

RESEARCHERS

SU2C’s scientists are the most capable, passionate and dedicated in their respective fields. This group of extraordinary individuals is constantly pushing towards progress, thus allowing for revolutionary discoveries. SU2C is supported by a team of more than 3,000 scientists from more than 210 prestigious medical and educational institutions that are united under one cause to end cancer as we know it.

Dream Teams, Research Teams, SU2C Convergence Teams, SU2C Catalyst® Teams, and through Innovative Research Grants.

RESEARCH PORTFOLIO

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.